IHCAI contributes to the Treatment of COVID-19

In order to contribute to the COVID-19 pandemic that seriously affects the global community, IHCAI Institute, as the headquarters of the Cochrane Center for Central America and the Caribbean, Cochrane Iberoamerica in 2020 in association with the DIME initiative, launched a selected information repository with full access and quick assessment by the editor body. The DIME program and IHcai partnership have been canceled since July 2021 We recommend using reliable information prepared by Cochrane Iberoamerican to guide both pharmacological and non-pharmacological decision-making for the treatment and prevention of COVID-19.

Please visit https://bit.ly/3p6UHAD